BI 3011441
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 3011441, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive) [Phase 1]